TL;DR
Overall, this study highlighted TMCO1 as a crucial regulator in ovarian cancer progression, influencing VDAC1 through CALR and impacting diverse cellular processes, offering potential as a targeted therapeutic strategy for ovarian cancer.
AI-generated by Semantic Scholar
Authors
Guangyu Sun, Shan Gong, Suwei Lan, Ying He, Yanhua Sun, Zhengmao Zhang
